Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

Stock market today: Dow, S&P 500, Nasdaq inch higher to kick off big week of Big Tech earnings, Fed meeting

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq inch higher to kick off big week of Big Tech earnings, Fed meeting US stocks nudged higher on Monday, as pressure built on the dollar and gold rallied to lead in a big week filled with a Federal Reserve rate decision and Big Tech earnings reports…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Tech sector issued nearly $700 billion in investment-grade debt over the past quarter, closing in on the just-over $800 billion in issuance by the financial sector

    80% confidence

  • Trump hinted he could name his choice of replacement for Powell as soon as this week

    80% confidence

  • Share of people citing an 'AI bubble' is falling

    80% confidence

  • Meta boosted spending projections from a range of $66 billion-$72 billion to between $70 billion and $72 billion

    80% confidence

  • Investors can't not consider the risks of bottomless spending and sky-high valuations

    80% confidence

  • Microsoft would spend more in 2026 than the $88.2 billion it spent in 2025

    80% confidence

  • Intel expects losses to continue into the first quarter

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq inch higher to kick off big week of Big Tech earnings, Fed meeting — Source | Via News | ViaNews Market